Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report

Br J Urol. 1990 Jul;66(1):58-65. doi: 10.1111/j.1464-410x.1990.tb14866.x.

Abstract

We describe the use of a new urethral stent implanted into 12 patients with prostatic outflow obstruction. All were in a high risk group for surgery and 11 were treated successfully, with a follow-up of 1 to 11 months (median 9). The majority of patients were satisfied with the procedure, which provided a quick, safe and effective alternative to conventional surgical treatment. The stent, woven from fine stainless steel in the form of a tubular mesh, was inserted via a delivery device using combined ultrasound and endoscopic control under local anaesthesia. The procedure was well tolerated, the stent becoming covered with epithelium by 6 to 8 months following insertion, yet allowing easy removal within the first 4 to 6 weeks should the need arise. This technique provides a useful alternative to conventional surgical treatment in the high risk patient.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Humans
  • Male
  • Prostatic Hyperplasia / complications*
  • Prostatic Hyperplasia / pathology
  • Risk Factors
  • Stents*
  • Time Factors
  • Ultrasonography
  • Urethra / pathology
  • Urethra / surgery
  • Urethral Obstruction / etiology
  • Urethral Obstruction / therapy*
  • Urodynamics